Financials

News Discussions Technicals Seasonals

SCP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Scope Fluidics SA engages in the research and development in the field of healthcare. It conducts projects for bacteria and virus detection, drug resistance and blood testing. The company's projects include PCR|ONE and BacterOMIC. Scope Fluidics was founded by Piotr Garstecki, Robert Piotr Holyst and Marcin Michal Izydorzak in 2010 and is headquartered in Warsaw, Poland.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

SCP has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company